Utikal J - Search Results

1

Elevated chronic inflammatory factors and myeloid-derived suppressor cells indicate poor prognosis in advanced melanoma patients.

Jiang H, Gebhardt C, Umansky L, Beckhove P, Schulze TJ, Utikal J, Umansky V. Jiang H, et al. Among authors: utikal j. Int J Cancer. 2015 May 15;136(10):2352-60. doi: 10.1002/ijc.29297. Epub 2014 Nov 12. Int J Cancer. 2015. PMID: 25353097

2

c-MYC and nodular malignant melanoma. A case report.

Greulich KM, Utikal J, Peter RU, Krähn G. Greulich KM, et al. Among authors: utikal j. Cancer. 2000 Jul 1;89(1):97-103. doi: 10.1002/1097-0142(20000701)89:1<97::aid-cncr14>3.0.co;2-0. Cancer. 2000. PMID: 10897006

3

Expression of c-myc and bcl-2 in primary and advanced cutaneous melanoma.

Utikal J, Leiter U, Udart M, Kaskel P, Peter RU, Krähn GM. Utikal J, et al. Cancer Invest. 2002;20(7-8):914-21. doi: 10.1081/cnv-120005904. Cancer Invest. 2002. PMID: 12449722

4

The expression of metastasis suppressor MIM/MTSS1 is regulated by DNA methylation.

Utikal J, Gratchev A, Muller-Molinet I, Oerther S, Kzhyshkowska J, Arens N, Grobholz R, Kannookadan S, Goerdt S. Utikal J, et al. Int J Cancer. 2006 Nov 15;119(10):2287-93. doi: 10.1002/ijc.22106. Int J Cancer. 2006. PMID: 16921485

5

Differential influence of vemurafenib and dabrafenib on patients' lymphocytes despite similar clinical efficacy in melanoma.

Schilling B, Sondermann W, Zhao F, Griewank KG, Livingstone E, Sucker A, Zelba H, Weide B, Trefzer U, Wilhelm T, Loquai C, Berking C, Hassel J, Kähler KC, Utikal J, Al Ghazal P, Gutzmer R, Goldinger SM, Zimmer L, Paschen A, Hillen U, Schadendorf D; DeCOG. Schilling B, et al. Among authors: utikal j. Ann Oncol. 2014 Mar;25(3):747-753. doi: 10.1093/annonc/mdt587. Epub 2014 Feb 6. Ann Oncol. 2014. PMID: 24504444 Free PMC article.

6

Multiple white cysts on face and trunk of a melanoma patient treated with vemurafenib.

Gebhardt C, Staub J, Schmieder A, Goerdt S, Utikal J. Gebhardt C, et al. Among authors: utikal j. Acta Derm Venereol. 2015 Jan;95(1):96-7. doi: 10.2340/00015555-1869. Acta Derm Venereol. 2015. PMID: 24710689 Free article. No abstract available.

7

Extracellular adenosine metabolism in immune cells in melanoma.

Umansky V, Shevchenko I, Bazhin AV, Utikal J. Umansky V, et al. Among authors: utikal j. Cancer Immunol Immunother. 2014 Oct;63(10):1073-80. doi: 10.1007/s00262-014-1553-8. Epub 2014 Apr 23. Cancer Immunol Immunother. 2014. PMID: 24756420 Free PMC article. Review.

8

Novel insights into exosome-induced, tumor-associated inflammation and immunomodulation.

Altevogt P, Bretz NP, Ridinger J, Utikal J, Umansky V. Altevogt P, et al. Among authors: utikal j. Semin Cancer Biol. 2014 Oct;28:51-7. doi: 10.1016/j.semcancer.2014.04.008. Epub 2014 Apr 24. Semin Cancer Biol. 2014. PMID: 24769223 Review.

9

Efficacy of vemurafenib in a trametinib-resistant stage IV melanoma patient--letter.

Bernhardt M, Orouji E, Larribere L, Gebhardt C, Utikal J. Bernhardt M, et al. Among authors: utikal j. Clin Cancer Res. 2014 May 1;20(9):2498-9. doi: 10.1158/1078-0432.CCR-13-2349. Clin Cancer Res. 2014. PMID: 24789037 No abstract available.

10

Complete remission of treatment-refractory advanced angiosarcoma of the scalp by protracted intralesional interleukin-2 therapy.

Gebhardt C, Ziegler B, Stadler S, Goerdt S, Utikal J. Gebhardt C, et al. Among authors: utikal j. Br J Dermatol. 2015 Apr;172(4):1156-8. doi: 10.1111/bjd.13400. Epub 2015 Feb 25. Br J Dermatol. 2015. PMID: 25204400 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

359 results

Search Page

Filters